WORLD AI
Venture Capital
At World AI Venture Capital, we are proud to support InVision, a groundbreaking medical technology company that is revolutionizing the way heart diseases are diagnosed. Founded in 2022 and based in Los Angeles, CA, InVision is using artificial intelligence (AI) to enhance the interpretation of ultrasound images, enabling faster and more accurate diagnoses of heart conditions.
About InVision
InVision’s innovative platform integrates seamlessly into existing clinical workflows, helping doctors and healthcare professionals swiftly interpret ultrasound scans to detect undiagnosed heart diseases. By leveraging AI, InVision’s technology allows for the automated analysis of medical images, enhancing decision-making processes and reducing the time required to identify critical health issues. This means patients can receive timely and accurate diagnoses, enabling better outcomes and more efficient care.
Recent Milestone
In September 2022, InVision successfully closed its Seed Round, marking an important milestone in its journey toward transforming the healthcare landscape. The company’s cutting-edge technology has the potential to make a significant impact in diagnostic medicine, and we are excited to be part of their journey.
Investor Support
World AI Venture Capital is thrilled to join other esteemed investors such as 10X Capital, Amino Capital, and Carnrite Ventures in backing this visionary company. With a strong foundation in AI and medical imaging, InVision is poised to help healthcare providers across the world adopt advanced, AI-driven solutions that improve diagnosis speed and accuracy.
The Future of Diagnostics
As healthcare continues to embrace AI-driven innovations, InVision’s platform represents a pivotal step forward in transforming medical diagnostics, particularly in the realm of heart disease detection. We look forward to seeing how InVision grows and scales, ultimately improving the lives of countless patients and advancing the field of medical technology.
For more information on InVision, visit: invisionmedtech.com.